StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
TMCI

Treace Medical Concepts, Inc.

TMCI Nasdaq Surgical & Medical Instruments & Apparatus EDGAR ↗
$4.68
+0.30 +6.85%

Key statistics

from XBRL data in SEC filings
Market cap
$304M
Revenue (TTM)
$207M
Net income (TTM)
-$61.0M
EPS (TTM)
$-0.96
P/E ratio
Dividend yield
Free cash flow
-$29.5M
Cash
$9.54M
Total assets
$184M
Gross margin
79.7%
52-week range
$1.17 – $7.78

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Shareholder vote results May 20, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release) May 8, 2026 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Apr 9, 2026 10-K Fiscal year ended 2025-12-31 Feb 27, 2026 8-K Results of operations (earnings release) Feb 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2026 8-K Entered a material agreement; Terminated a material agreement; Took on a direct financial obligation; Modified rights of security holders; Regulation FD disclosure; Other events Dec 18, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Director or officer change Nov 6, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Shareholder vote results May 21, 2025 10-Q Quarter ended 2025-03-31 May 8, 2025 8-K Results of operations (earnings release) May 8, 2025 8-K Director or officer change Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 5, 2024 8-K Results of operations (earnings release) Nov 5, 2024 8-K Regulation FD disclosure Oct 15, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Shareholder vote results May 22, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 7, 2024 10-K Fiscal year ended 2023-12-31 Feb 27, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Feb 27, 2024 8-K Regulation FD disclosure Jan 10, 2024 8-K Results of operations (earnings release) Jan 8, 2024 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Nov 9, 2023 10-Q Quarter ended 2023-06-30 Aug 9, 2023 8-K Results of operations (earnings release) Aug 8, 2023 8-K Completed an acquisition or disposition Jun 13, 2023 8-K Regulation FD disclosure; Other events Jun 1, 2023 8-K Shareholder vote results May 26, 2023 10-Q Quarter ended 2023-03-31 May 9, 2023 8-K Results of operations (earnings release) May 8, 2023